Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGastroenterologyBaylor Scott & White POEM Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentBaylor Scott & White Health PlanPolicy 228

    Peroral Endoscopic Myotomy (POEM) for Esophageal Achalasia

    Customize your policy alerts

    Sign up for baylor_scott_and_white_health_plan Policy 228 alerts

    Get alerted when Policy 228 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical-necessity consideration for POEM in adults with esophageal achalasia, subject to applicable benefit documents, plan-specific rules, and federal or Texas Medicaid guidance.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyPeroral Endoscopic Myotomy (POEM) for Esophageal Achalasia
    Policy CodePolicy 228
    Change TypeRevised inclusion criteria
    Effective DateSep 1, 2026
    Last ReviewJul 23, 2026
    Next Review DateJul 23, 2027
    Key ActionDocument the member's age, achalasia type and diagnosis by esophageal manometry, Eckardt symptom score, and completion of upper endoscopy, timed barium esophagram, and high-resolution manometry.
    SourceLink
    POLICY UPDATE CHANGES

    The policy's inclusion criteria were updated in the latest review.

    18+Minimum member age
    I, II, IIIEligible achalasia types
    >= 3Required Eckardt score
    3Required diagnostic studies

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    43497
    Covered CPT code

    Medical Necessity Criteria

    POEM for Esophageal Achalasia

    POEM may be considered medically necessary when ALL of the following are met.

    Medical-necessity criteria

    • Member and diagnosis

      • Age: Member is age 18 years or older.>= 18 years
      • Achalasia diagnosis: Member has achalasia type I, II, or III diagnosed using esophageal manometry.Types I, II, or III

        Diagnosis must use esophageal manometry.

      • Symptom severity: Member has an Eckardt symptom score of at least 3.>= 3
    • Comprehensive diagnostic workup

      • Upper endoscopy has been performed.
      • Timed barium esophagram has been performed.
      • High-resolution manometry has been performed.

    POEM is contraindicated in members with severe erosive esophagitis, significant coagulation disorders, liver cirrhosis with portal hypertension, or prior therapy that may compromise the integrity of the esophageal mucosa or cause submucosal fibrosis, including radiation, endoscopic mucosal resection, or radiofrequency ablation. Previous achalasia treatments, such as pneumatic balloon dilation, botulinum toxin injection, or surgical myotomy, are not themselves contraindications to POEM.

    POEM for any indication other than esophageal achalasia is considered experimental, investigational, and unproven.

    Billing and Eligibility Codes

    Covered CPT CodesCPTCovered
    43497Lower esophageal myotomy, transoral (ie, peroral endoscopic myotomy [POEM])
    ICD10 Not coveredICD-10Not Covered
    K22.0Achalasia of cardia
    Member Age
    Minimum age18 years
    RequirementMember is age 18 years or older
    Applies toMembers considered for POEM for esophageal achalasia
    Eckardt Symptom Score
    Required scoreAt least 3
    Clinical measureEckardt symptom score
    Policy roleRequired criterion for POEM to be considered medically necessary

    Documentation and Review Requirements

    Documentation Required

    Required Clinical Documentation

    Document that the member meets the required clinical criteria for POEM, including age, achalasia diagnosis and type confirmed by esophageal manometry, Eckardt symptom score, and comprehensive diagnostic workup.

    • Age 18 years or older
    • Achalasia type I, II, or III diagnosed using esophageal manometry
    • Eckardt symptom score of at least 3
    • Comprehensive diagnostic workup including upper endoscopy, timed barium esophagram, and high-resolution manometry
    Documentation Required

    Contraindication and Prior-Treatment Review

    Before requesting POEM, document review of contraindications and the member’s prior achalasia treatment history. Prior pneumatic balloon dilation, botulinum toxin injection, or surgical myotomy are not contraindications to POEM; however, therapies that may compromise the esophageal mucosa or cause submucosal fibrosis must be specifically assessed.

    • Document the contraindication assessment and relevant prior treatment history

    Clinical Background

    Peroral Endoscopic Myotomy (POEM) is a less invasive alternative to laparoscopic myotomy for esophageal achalasia. Using a natural-orifice transmural endoscopic approach, an endoscope is passed through the esophagus, a submucosal tunnel is created, and muscle fibers in the lower esophagus and proximal stomach are divided. POEM, laparoscopic Heller myotomy, and pneumatic dilation are effective therapies for type I and II achalasia; treatment selection is informed by patient and disease characteristics, patient preferences, and local expertise. POEM is described as the preferred treatment for type III achalasia, and patients should be counseled about the increased risk of postprocedure reflux.

    Key Definitions

    Peroral Endoscopic Myotomy (POEM)
    TechniqueNatural-orifice transmural endoscopic surgery (NOTES)
    Access routeAn endoscope is passed through the esophagus
    ProcedureA tunnel is created to access the lower esophagus, and muscle fibers in the lower esophagus and proximal stomach are cut
    Eckardt Symptom Score
    DefinitionA symptom score used to assess symptoms in members being considered for POEM
    Required thresholdAt least 3
    Medical-necessity role
    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyPeroral Endoscopic Myotomy (POEM) for Esophageal Achalasia
    Policy CodePolicy 228
    Change TypeRevised inclusion criteria
    Effective DateSep 1, 2026
    Last ReviewJul 23, 2026
    Next Review DateJul 23, 2027
    Key ActionDocument the member's age, achalasia type and diagnosis by esophageal manometry, Eckardt symptom score, and completion of upper endoscopy, timed barium esophagram, and high-resolution manometry.
    SourceLink
    On This Page
    Medical Necessity CriteriaBilling and Eligibility CodesDocumentation and Review RequirementsClinical BackgroundKey Definitions
  1. Identify prior radiation, endoscopic mucosal resection, or radiofrequency ablation
  2. Denial Risk

    Contraindications

    POEM is contraindicated when any of the following conditions are present.

    • Severe erosive esophagitis
    • Significant coagulation disorders
    • Liver cirrhosis with portal hypertension
    • Prior therapy that may compromise the integrity of the esophageal mucosa or lead to submucosal fibrosis, such as radiation, endoscopic mucosal resection, or radiofrequency ablation
    Denial Risk

    Other Indications

    POEM for any indication other than esophageal achalasia is considered experimental, investigational, and unproven.

    • Do not submit POEM for non-achalasia indications as a medically necessary covered service
    The score must be at least 3 for POEM to meet the policy's medical-necessity criteria